According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), Beneficient plans to issue an additional promissory note worth $2 million to the investment institution Yorkville, following SEC approval.

This move marks a further expansion of the existing financing arrangements between both parties. Previously, there was already a similar financing instrument between Beneficient and Yorkville. The issuance of the new promissory note must be conducted under the premise of meeting relevant SEC regulatory requirements. The documents disclosed this financing plan but did not specify the exact purpose of the funds or detailed terms of the promissory note. Typically, such financing may be used for company working capital, specific project investments, or other general corporate purposes. The market will pay attention to how this capital injection will impact Beneficient's financial position and subsequent business development.